This content is machine translated GLP-1 receptor agonists (GLP-1-RA) Type 2 diabetics benefit from dulaglutide in several ways The ADA/EASD guidelines recommend individualized therapy choices for type 2 diabetics. GLP-1 receptor agonists not only improve glycemic control, but also support weight loss, reduce the risk of cardiovascular disease,…
View Post 4 min This content is machine translated Study Overview What’s new in the world of cardiology? Scientific research is constantly being pursued, enabling advances to be made time and again in the therapeutic management of cardiological diseases. The most interesting study results around pericarditis, chronic coronary…
View Post 5 min This content is machine translated Corona pandemic Diabetes patients with COVID-19: current expert assessment. Poorly controlled diabetes is a risk factor for severe COVID-19 progression. Therefore, especially during the corona pandemic, the best possible blood glucose control is crucial. However, it has been shown…
View Post 5 min This content is machine translated Non-resectable gastric carcinoma Immunotherapy on the rise The prognosis of advanced gastric carcinoma remains extremely unfavorable. Accordingly, new treatment approaches are urgently needed. Current evidence suggests that checkpoint inhibitor therapy may become more important in the near…
View Post 16 min This content is machine translated Type 2 diabetes The cardiovascular diabetic patient – an interdisciplinary challenge A patient with type 2 diabetes is 2-3 times more likely to have a myocardial infarction or stroke than people without diabetes. Cardiovascular disease accounts for up to 50% of… CME-Test
View Post 4 min This content is machine translated COPD therapy The less eosinophilic the COPDer, the more unnecessary the ICS “Treatable traits” is the new magic term in the treatment of COPD, and the current guidelines are modeled after it. With regard to the structure of therapy, the focus should…
View Post 7 min This content is machine translated Lupus nephritis Special case kidney For a long time, the treatment of lupus was characterized by stagnation. However, after 20 years of frustration, there is finally movement to develop new therapeutic options. Studies have produced promising results…
View Post 3 min This content is machine translated Multiple sclerosis Current treatment strategies to halt progression. In most cases, multiple sclerosis is relapsing and can progress to a chronic progressive stage over time. Which therapy management is used depends not only on the individual circumstances but also…
View Post 1 min This content is machine translated SGAI expert assessment COVID-19 vaccinations in persons with allergic diseases. The Swiss Society of Allergology and Immunology (SGAI) has issued recommendations on what to look for in patients with known pre-existing allergic conditions when vaccinating against SARS-CoV-2.
View Post 4 min This content is machine translated Chronic inflammatory bowel disease (CED) Two new biomarkers identified for targeted therapy Surrogate markers have an important role in the disease management of IBD. Researchers found evidence that microbial butyrate synthesis may predict therapeutic efficacy and thus play an important role in…
View Post 6 min This content is machine translated Therapy of metastatic HER2-positive breast carcinoma Is a cure possible soon? In recent years, the prognosis of metastatic HER2-positive breast carcinoma has been significantly improved by the development of new agents such as the antibody-drug conjugate (ADC) trastuzumab-deruxtecan and the HER2-targeted…
